These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18405524)

  • 21. Atrioventricular junction ablation followed by resynchronization therapy in patients with congestive heart failure and atrial fibrillation (AVERT-AF) study design.
    Hamdan MH; Freedman RA; Gilbert EM; Dimarco JP; Ellenbogen KA; Page RL
    Pacing Clin Electrophysiol; 2006 Oct; 29(10):1081-8. PubMed ID: 17038140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 'Happy Ending Problem' of cardiac pacing? Cardiac resynchronization therapy for patients with atrial fibrillation and heart failure after atrioventricular junction ablation.
    Szili-Torok T; Mihalcz A; Jordaens L
    Europace; 2008 Jul; 10(7):779-81. PubMed ID: 18515788
    [No Abstract]   [Full Text] [Related]  

  • 23. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure.
    Leclercq C; Gadler F; Kranig W; Ellery S; Gras D; Lazarus A; Clémenty J; Boulogne E; Daubert JC;
    J Am Coll Cardiol; 2008 Apr; 51(15):1455-62. PubMed ID: 18402900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The influence of radiofrequency (RF) ablation of the atrioventricular junction in atrial fibrillation on left ventricular systolic function, exercise tolerance and quality of life].
    Lelakowski J; Majewski J; Bigaj J; Szczepkowski J; Dreher A; Bednarek J
    Przegl Lek; 2009; 66(5):222-7. PubMed ID: 19739578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis.
    Stavrakis S; Garabelli P; Reynolds DW
    Europace; 2012 Oct; 14(10):1490-7. PubMed ID: 22696519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation.
    Lellouche N; De Diego C; Vaseghi M; Buch E; Cesario DA; Mahajan A; Wiener I; Fonarow GC; Boyle NG; Shivkumar K
    Pacing Clin Electrophysiol; 2007 Nov; 30(11):1363-8. PubMed ID: 17976100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional impact of rate irregularity in patients with heart failure and atrial fibrillation receiving cardiac resynchronization therapy.
    Melenovsky V; Hay I; Fetics BJ; Borlaug BA; Kramer A; Pastore JM; Berger R; Kass DA
    Eur Heart J; 2005 Apr; 26(7):705-11. PubMed ID: 15618039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dynamic of the changes of the paced QT dispersion after ventricular pacemaker implantation (WIR) and radiofrequency atrioventricular junction ablation in drug refractory atrial fibrillation].
    Lelakowski J; Majewski J; Szczepkowski J; Dreher A; Bednarek J; Małecka B
    Przegl Lek; 2008; 65(2):61-7. PubMed ID: 18663902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac resynchronization therapy in the setting of permanent atrial fibrillation and heart failure.
    Koneru JN; Steinberg JS
    Curr Opin Cardiol; 2008 Jan; 23(1):9-15. PubMed ID: 18281821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoring sinus rhythm in patients with previous pacemaker implantation submitted to cardiac surgery and concomitant surgical ablation of atrial fibrillation.
    Marques MP; Melo JQ; Knaut M; Alfieri O; Benussi S; Williams MR; Hornero F
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):596-9. PubMed ID: 18282759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The North American experience with the Ablate and Pace Trial (APT) for medically refractory atrial fibrillation.
    Wood MA; Kay GN; Ellenbogen KA
    Europace; 1999 Jan; 1(1):22-5. PubMed ID: 11220534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac resynchronization therapy and atrial fibrillation.
    Kamath GS; Steinberg JS
    Cardiol J; 2009; 16(1):4-10. PubMed ID: 19130410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrioventricular nodal modification and atrioventricular junctional ablation for control of ventricular rate in atrial fibrillation.
    Narasimhan C; Blanck Z; Akhtar M
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S146-50. PubMed ID: 9727690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of pacemaker dependence in patients on ablate and pace therapy for atrial fibrillation.
    Occhetta E; Bortnik M; Dell'era G; Zardo F; Dametto E; Sassone B; Gabrieli L; Marino P
    Europace; 2007 Dec; 9(12):1119-23. PubMed ID: 17959682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrioventricular junction ablation in cardiac resynchronization therapy.
    Foley P; Smith R; Leyva F
    Br J Hosp Med (Lond); 2009 Feb; 70(2):112. PubMed ID: 19229156
    [No Abstract]   [Full Text] [Related]  

  • 39. The Atrial Pacing Peri-ablation for Paroxysmal Atrial Fibrillation (PA3) Study: rationale and study design.
    Gillis AM
    Europace; 1999 Jan; 1(1):40-2. PubMed ID: 11220538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AV junctional ablation allowing more effective delivery of cardiac resynchronization therapy in patients with intra- and interatrial conduction delay.
    Herweg B; Ilercil A; Madramootoo C; Ali R; Barold SS
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):685-90. PubMed ID: 18507540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.